What is it about?
It is a cross-sectional study that analyzes the correlations of plasma endoglin levels with different cardiovascular alterations in patients suffering from hypertension and/or diabetes. The article evidences that the increase in plasma endoglin levels may serve as an indicator of cardiovascular alterations in those patients.
Featured Image
Why is it important?
This is the first study in humans suggesting that plasma soluble endoglin concentration could serve as an indicator of diabetes-associated pathologies such as hypertension, endothelial dysfunction and cardiovascular risk
Read the Original
This page is a summary of: Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients, BMC Medicine, December 2010, Springer Science + Business Media,
DOI: 10.1186/1741-7015-8-86.
You can read the full text:
Contributors
The following have contributed to this page